Type 2 diabetes Chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Type 2 diabetes or chronic kidney disease 2. Urine specimens stored at the Division of Clinical Nephrology and Rheumatology or Department of Applied Molecular Medicine, Niigata University, with informed consent to participate in this clinical study, which was approved by the Ethics Committee of Niigata University (approval no. 191 in 2003)
Exclusion criteria
Exclusion criteria: 1. Severe active infection or severe trauma 2. Pregnancy 3. Deemed ineligible for this study by attending doctors for any medical reason 4. Declining analysis of their urine samples 5. Short observation period (less than 6 months)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Associations of urinary megalin excretion and megalin ligand molecules (e.g., alfa 1-microglobulin, beta 2-microglobulin) with changes in estimated glomerular filtration rate, urinary albumin/creatinine ratio, and urinary protein levels | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in body weight, blood pressure, and HbA1c during the observation period 2. Changes in other biomarkers (urinary podocalyxin, etc.) during the observation period | — |
Countries
Japan
Contacts
Niigata University Graduate School Of Medical and Dental Science Department of Clinical Nutrition Science, Kidney Research Center